The use of danazol in the treatment of painful benign breast disease: preliminary results
RCT
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
Danazol was found to be more effective than placebo in a preliminary double-blind trial for treating severe cyclical breast pain in women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The preliminary results of a double-blind randomized cross-over trial of danazol versus placebo in patients with severe cyclical breast pain are reported. Though numbers are small at present, the results are encouraging.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease 1982
- Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. A double-blind placebo-controlled study--the Hjørring project 1984
- Cyclical mastopathy: a critical review of therapy 1988
Cited by (3)
- Cyclical mastopathy: a critical review of therapy 1988
- Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. A double-blind placebo-controlled study--the Hjørring project 1984
- Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease 1982
Source provenance
- openalex
- last seen: 2026-05-10T11:27:34.415878+00:00
- pubmed
- last seen: 2026-10-08T21:46:40.609885+00:00
License: CC0
· commercial use OK